Objective: To determine the in vitro inhibitory activity of green tea extract on some clinically isolated cariogenic and periodontopathic bacteria. Materials and Methods: Twenty strains of each of Streptococcusmutans, Aggregatibacteractinomycetemcomitans, Porphyromonasgingivalis, and Prevotellaintermedia were isolated from carious teeth and periodontal pockets of patients with dental caries and periodontal diseases. Green tea extract was prepared by aqueous extraction method and diluted from 50 to 1.56 mg/ml. Standard techniques of agar disk diffusion and broth microdilution assays were applied for qualitative and quantitative determinations of antibacterial activity of green tea extract on each isolates. Results: All clinical isolates of S. mutans (100%) were sensitive to green tea extract at concentrations 6.25, 12.5, 25, and 50 mg/ml producing inhibition zones ranging from 10 to 38 mm. All periodontopathic isolates (A. actinomycetemcomitans, n = 20, P. intermedia, n = 20, and P. gingivalis, n = 20) (100%) tested were sensitive to 12.5, 25, and 50 mg/ml of this extract. The minimal inhibitory concentration of green tea extract for S. mutans was 3.28 ± 0.7 mg/ml and for A. actinomycetemcomitans 6.25, for P. gingivalis and P. intermedia 12.5 mg/ml. Conclusions: Our findings showed that green tea extract exhibited strong antibacterial activity on S. mutans,A. actinomycetemcomitans,P. gingivalis and P. intermedia and therefore may be used in mouthwashes or dentifrices for prevention of dental caries and periodontal diseases.

Green tea is one of the most popular beverages consumed worldwide. Moreover, during the last two decades it has received much attention in regard to its beneficial effects on various human health problems [1]. Tea prepared from Camellia sinensis is of three types: nonfermented green tea that is panfried or steamed and dried to inactivate its enzymes, fermented black tea and semifermented oolong tea. Green tea with active chemical ingredients possesses diverse pharmacological properties which are linked to lower incidence of some pathological conditions including oral cancer, dental caries, stroke, cardiovascular diseases and obesity [1,2,3]. Moreover, various reports on antimicrobial, antifungal, antioxidant, and cholesterol lowering activities of green tea and its constituents are documented [2,3,4,5,6,7]. The health-promoting effects of green tea are mainly attributed to its polyphenol contents commonly referred to as catechins. There are four main types of catechins: epigallocatechin-3-gallate (EGCG), epigallocatechin, epicatechin-3-gallate and epicatechin [3]. The polyphenol contents of green tea have been reported to inhibit varieties of pathogenic bacterial growth such as Helicobacter pylori, methicillin-resistant Staphylococcus aureus, Streptococcus mutans, Streptococcus sobrinus, Salmonella typhi, Shigella dysentery, Shigella flexneri and Vibriocholera [3,5,6,7,8,9]. Green tea polyphenols were also found effective against human immunodeficiency virus, hepatitis, and influenza viruses [10,11]. Dental caries and periodontal diseases are the two most prevalent plaques associated with oral infectious diseases produced by endogenous oral flora. S. mutans and S. sobrinus are known as the main etiological agents of dental caries. These cariogenic bacteria adhere to the tooth surface and produce a sticky glycocalyx film composed of glucan resulting from the action of glucosyltransferase on dietary sucrose. Accumulation of bacteria causes dental plaque formation within which there is continuing acid production by the bacterial plaque. Accumulation of high acid concentration in the plaque causes demineralization of enamel which consequently leads to caries formation. Periodontitis is a chronic slowly progressive polymicrobial infectious disease which affects the entire tooth-supporting tissues. This infection is characterized by destruction of alveolar bone, periodontal ligaments and gingival pocket formation which consequently leads to tooth loss. Periodontitis is known to be caused by subgingival plaque bacteria including Aggregatibacter actinomycetemcomitans, Prevotella intermedia, Porphyromonas gingivalis, Tannerellaforsythus and Fusobacterium species. These bacteria are frequently isolated from gingival pocket and subgingival plaques of patients with periodontitis. In the present study we investigated reporting the inhibitory activity of green tea extract (GTE) on some clinically isolated cariogenic and periodontopathic bacteria.

Isolation of S. mutans from Carious Teeth

S. mutans were isolated from carious teeth as described previously [12]. Briefly, the extracted carious teeth were incubated in 10 ml Todd-Hewitt broth (Merck, Germany) at 37°C, 5% CO2 for 48 h. A Mitis-Salivarius-bacitracin agar was then subcultured from Todd-Hewitt broth and incubated at 37°C, 5% CO2 for 72 h. S. mutans were then identified by biochemical tests [12]. Pure cultures of each clinical isolate of S. mutans were cultivated on Mitis-Salivarius-bacitracin agar and kept at 4°C until used.

Isolation of Periodontopathic Bacteria

Patients with either aggressive or localized aggressive periodontitis were examined and sampled for isolation of A. actinomycetemcomitans,P. gingivalis and P. intermedia [13]. Subgingival pocket samples were taken from the deepest part of periodontal pockets (probing depth ≥6 mm) by insertion of a sterile paper point (Iso 35, Bocht, Offenburg, Germany). Each sample was inoculated into 5 ml of Trypticase soy broth containing hemin and menadione (Becton Dickinson Microbiology System) and kept under anaerobic conditions at 37°C, 5% CO2 for 48 h. Bacteria from Trypticase soy broth were then subcultured on Trypticase soy-blood agar (TSBA) plates and kept under anaerobic conditions, 5% CO2, 37°C for 72 h. The periodontopathic bacteria were isolated and characterized as reported elsewhere [13]. Pure cultures of each isolate were prepared on TSBA and kept at 4°C until used.

In the present study 20 clinical strains of each of S. mutans, A. actinomycetemcomitans,P. gingivalis, and P. intermedia isolated from carious teeth and periodontal pockets of patients with periodontitis were used for GTE antibacterial activity by standard methods.

Preparations of Green Tea Extract

Green tea used in this study had been grown in Lahijan tea farm, in the northern part of Iran and has been purchased from a local store. GTE was prepared according to Yam et al. [5] with minor modifications. Briefly, 200 g of dried crushed green tea leaves were extracted into 500 ml boiling distilled water for 2 h. Insoluble particles were then removed by high speed centrifugation and filtration. The filtrate was reduced to 120 ml in a rotary evaporator and extracted 5 times with 180 ml of ethyl acetate. The organic phases were combined and concentrated to about 25 ml in a rotary evaporator and 25 ml of distilled water were added and the remaining ethyl acetate and aqueous phase was freeze-dried. Five grams of the dried precipitate was dissolved in 100 ml of phosphate-buffered saline (pH = 7.4) and used as stock solution of GTE (50 mg/ml). Twofold dilutions from the stock solution, i.e., 25, 12.5, 6.25, 3.12, and 1.56 mg/ml were prepared and used for antibacterial assays.

Antibacterial Assays

Standard agar disk diffusion (ADD) and broth microdilution methods were used to determine the inhibitory activity of GTE both qualitatively and quantitatively.

Agar Disk Diffusion

The cariogenic and periodontopathic bacteria isolates were subjected to ADD susceptibility testing using various dilutions of GTE on semisolid media [12,13]. Mitis-Salivarius-Bacitracin agar plates were used for S. mutans and TSBA plates for A. actinomycetemcomitans, P. gingivalis and P. intermedia. S. mutans ATCC 25175, A. actinomycetemcomitans ATCC 29523 and P. gingivalis ATCC33277 were used as standard control isolates. These strains were maintained anaerobically on TSBA supplemented with 10% defibrinated horse blood and hemin (5 µg/ml; Wako Pure Chemical Industries, Osaka, Japan). A pure bacterial cell suspension of each clinical isolate was prepared in 5 ml of Todd-Hewitt broth (S. mutans) or 5 ml Trypticase soy broth (A. actinomycetemcomitans, P. gingivalis, and P. intermedia); the suspension turbidity was adjusted to 1.5 × 108 colony-forming units (CFU)/ml equivalent to McFarland standard No. 0.5. A 100-µl sample of this suspension was seeded onto semisolid appropriate media. A 6-mm-diameter sterile Whatman filter paper No. 5 (round filter Machery-Nagel, Doren, Germany) was impregnated with 50 µl of various concentrations (50, 25, 12.5, 6.25, 3.12, 1.56 mg/ml) of GTE, placed on the above agar culture media and incubated at 37°C under anaerobic condition for 72 h. The diameter of the zone of growth inhibition around the disk was measured in millimeters, mean and standard deviation (SD) were calculated and recorded. Disks containing GTE which did not produce inhibition zones were considered as negative results. Sterile filter paper disks soaked in 50 µl of phosphate-buffered saline, pH = 7.4, and antibiotic disks of vancomycin (30 µg) and amikacin (30 µg) were also used as controls.

Broth Microdilution Method for Determination of Minimal Inhibitory Concentration

Broth microdilution methods were carried out in 96-well culture plates to determine the minimal inhibitory concentration (MIC) of GTE against cariogenic and periodontopathic isolates [13,14]. Todd-Hewitt broth was used for S. mutans and Trypticase soy broth containing menadione and hemin was used for A. actinomycetemcomitans, P. gingivalis and P. intermedia. Bacterial cell suspensions of each of the clinical isolates were prepared in the above liquid media and their concentrations were adjusted to 107 CFU/ml. Twofold dilutions of GTE were prepared in the appropriate broth culture media from stock solution. Aliquots (200 µl) of each dilution of GTE were dispensed in 96-well culture plates. One hundred microliters of each bacterial suspension was added to each well and incubated under anaerobic conditions in 5% CO2 at 37°C for 48 h. The absorbance was then measured at 595 nm. The highest dilution of GTE at which no growth (OD ≤0.05) was observed, was defined as MIC.

The results of GTE antibacterial activity on the cariogenic and periodontopathic bacteria studied by ADD tests are given in table 1.

Table 1

Inhibitory activity of various concentrations of GTE on some clinically isolated cariogenic and periodontopathic bacteria by ADD test

Inhibitory activity of various concentrations of GTE on some clinically isolated cariogenic and periodontopathic bacteria by ADD test
Inhibitory activity of various concentrations of GTE on some clinically isolated cariogenic and periodontopathic bacteria by ADD test

All isolates of S. mutans (100%) were sensitive to the extract at concentrations of 6.25, 12.5, 25, and 50 mg/ml and exhibited growth inhibition zones ranging from 10 to 38 mm. At 3.12 mg/ml, 18/20 (90%) of S. mutans isolates were sensitive, producing inhibition zones of 6-10 mm. A. actinomycetemcomitans, P. gingivalis and P. intermedia were sensitive to GTE at concentrations of 12.5, 25, and 50 mg/ml and produced inhibition zones ranging from 10 to 30 mm in diameter (table 1). At the concentration of 6.25 mg/ml of GTE, 75% (n = 15) of P. gingivalis, 70% (n = 14) of A. actinomycetemcomitans, and 65% (n = 13) of P. intermedia were sensitive. None of the bacterial isolates were sensitive to 1.56 mg/ml or less. The MIC results of GTE on S. mutans and periodontopathic bacteria are shown in table 2. The MIC of GTE for S. mutans was 3.28 ± 0.699 and for A. actinomycetemcomitans was 6.25, for P. gingivalis and P. intermedia 12.5 mg/ml. The MICs of GTE on S. mutans (ATCC 25175), A. actinomycetemcomitans (ATCC 29523) and P. gingivalis (ATCC 33277) were 6.25, 12.5, and 12.5 mg/ml, respectively.

Table 2

MICs of GTE (mg/ml) on some clinically isolated cariogenic and periodontopathic bacteria by broth microdilution method

MICs of GTE (mg/ml) on some clinically isolated cariogenic and periodontopathic bacteria by broth microdilution method
MICs of GTE (mg/ml) on some clinically isolated cariogenic and periodontopathic bacteria by broth microdilution method

The crude GTE exhibited strong inhibitory activity on S. mutans, A. actinomycetemcomitans, P. gingivalis and P. intermedia. However, S. mutans was more susceptible than periodontopathic bacteria as crude GTE produced growth inhibition zones up to 36.3 mm by ADD test (table 1) and MIC was as low as 3.28 mg/ml (table 2). Ikigai et al. [15] reported statistically significantly lower MIC of EGCG for S. aureus (73 µg/ml) versus MIC for Escherichia coli (183 µg/ml). The same authors also found epicatechin to be much less active than EGCG with MICs of 573 and ≤1,104 µg/ml for S. aureus and E. coli, respectively. In our study, the MIC of crude GTE was higher for Gram-negative periodontopathic bacteria (A. actinomycetemcomitans, P. gingivalis and P. intermedia) than for Gram-positive bacteria (S. mutans). The higher MIC values of crude GTE and catechins for Gram-negative than Gram-positive bacteria of this study confirmed those of previous studies. Our study also confirmed the greater susceptibility of Gram-positive bacteria, an effect that might be due to differences in cell wall structure and polysaccharide charges of the bacteria. Our data revealed strong inhibitory activity of crude GTE on clinically isolated periodontopathic bacteria as this extract produced growth inhibition zones ranging from 11.65 to 27.25 mm in ADD and MIC of 6.25-12.5 mg/ml by broth microdilution method. The inhibitory activity of GTE on periodontopathic bacteria is attributed to polyphenol catechins and particularly EGCG. It has been shown that adherence and colonization of P. gingivalis on the buccal epithelial cells was completely inhibited in the presence of EGCG at concentrations of 250-500 µg/ml while other polyphenolic compounds were not as effective as EGCG at this concentration [16]. The precise mechanism of action of EGCG remains unclear, however, several mechanisms have been proposed for the anticariogenic and antiperiodontopathic activities of tea polyphenol galloylated catechins. EGCG has been shown to cause irreversible membrane disruption in both Gram-positive and Gram-negative bacteria [15] and also to inhibit bacterial DNA gyrase preventing DNA supercoiling and leading to bacterial cell death [17]. EGCG neutralizes toxic end metabolites such as collagenase, protein tyrosine phosphatase, alkaline phosphatase, and gingipains of periodontopathic bacteria, which causes destruction of gingival tissues and progression of periodontitis [18,19]. Furthermore, EGCG has been shown to inhibit proliferation of S. mutans, interfere with the bacterial adhesion process to the enamel and also suppress glucosyltransferase and amylase activities, which consequently leads to reduced acid production in the dental plaques [16,20,21].

Effective prevention of dental caries and periodontal disease could be achieved by proper and regular toothbrushing, flossing and rinsing with mouthwashes containing antibacterial agents such as chlorhexidine, sodium hypochlorite, cetylpyridinium chloride and amine fluoride. Moreover, chlorhexidine gluconate and sodium hypochlorite were shown to be cytotoxic to human periodontal ligament cells, inhibit protein synthesis, affect mitochondrial activity of these cells and consequently may have detrimental effects on vital tissues [22,23]. Considering the potential disadvantages and side effects of these chemical agents, there is a need for more agents with marked antibacterial activity, greater sensitivity and less toxicity to be used as mouthwashes and irrigating agents. During the last decade much attention has been given to the antimicrobial activities of medicinal plants and their extracts to be consumed as useful alternatives to synthetic chemical agents [12,13,24,25]. Among the medicinal plants, green tea is of particular interest and has been used therapeutically for a long time in various parts of the world [1,2,3,4,5,6,7,8,9,16]. Most of the biological activities of green tea, particularly its antibacterial properties, have been associated with the polyphenol catechin fractions which constitute up to 30% of solid green tea leaves [1,3]. EGCG is the most abundant of these catechins, comprising about 50% of the catechin pool [1]. It has been shown that catechin components of green tea and particularly EGCG, epigallocatechin and epicatechin-3-gallate, which are all catechin derivatives having a galloyl moiety linked by an ester linkage, constitute the most important antibacterial agents in GTE [1,3,16].

Several investigators have reported that catechins are inhibitory for S. mutans with MIC ranging from 50-1,000 µg/ml [16,26]. Xu et al. [27] reported that EGCG inhibited growth of S. mutans at an MIC of 31.25 µg/ml and minimum bactericidal concentration of 62.5 µg/ml. On the other hand, Muroi and Kubo [28] found no significant antibacterial activity of EGCG against oral streptococci at 500 µg/ml. Sasaki et al. [26] reported that combination of EGCG, GCG and CG exhibited stronger antibacterial activity against S. mutans MT8148R whereas pure EGCG, GCG and CG products individually showed only a moderate or low level of antibacterial activity against S. mutans. Although EGCG is the most potent antibacterial catechin, it is reasonable to assume that synergistic action may exist between the above-mentioned galloylated catechins and therefore consumption of crude GTE seems to be more useful than the pure catechins.

Green tea is safe for most of the people when used in moderate quantities. The most adverse effects of green tea administered orally are gastrointestinal upset and central nervous system stimulation from the caffeine content of the tea. There are several case reports of hepatotoxicity linked to GTE products in pill or beverage form, however, the mechanism of this symptom is not known [29]. Allergic reactions have been reported with topical green tea ointment, which may cause cervical and vaginal inflammation, irritation and vulvar burning [30].

Data presented in this study revealed in vitro inhibitory activities of GTE on cariogenic and periodontopathic bacteria and concluded that they could be used in mouthwashes for dental caries and periodontal disease prevention.

The authors would like to thank the vice chancellor of research, Hormozgan University of Medical Sciences, for financial support of this project (grant No. 4664). The editorial assistance of Azadeh Kohanteb is greatly appreciated.

1.
Chacko SM, Thambi PT, Kuttan R, et al: Beneficial effects of green tea: a literature review. Chin Med 2010;5:1-13.
2.
Schneider C, Segre T: Green tea potential health benefit. Am Fam Physician 2009;79:591-594.
3.
Taylor PW, Hamilton-Miller JMT, Stapleton PD: Antimicrobial properties of green tea catechins. Food Sci Technol Bull 2005;2:71-81.
4.
Higdon JV, Frei B: Tea catechins and polyphenols: health effects, metabolism and antioxidant functions. Crit Rev Food Sci Nutr 2003;43:89-143.
5.
Yam TS, Shah S, Hamilton-Miller JTM: Microbiological activity of whole and fractionated crude extract of tea (Camellia sinensis) and of tea components. FEMS Microbiol Lett 1997;152:169-174.
6.
Archana S, Abraham J: Comparative analysis of antimicrobial activity of leaf extracts from fresh green tea and black tea on pathogens. J Appl Pharm Sci 2011;8:149-152.
7.
Stoicov C, Safari R, Houghton J: Green tea inhibits Helicobacter growth in vivo and in vitro. Int J Antimicrob Agents 2009;33:473-478.
8.
Tiwari RP, Barti Sk, Kaur HD, et al: Synergistic antimicrobial activity of tea and antibiotics. Indian J Med Res 2005;122:80-84.
9.
Sakanaka S, Aizawa M, Kim M, et al: Inhibitory effects of green tea polyphenols on growth and cellular adherence of an oral bacterium, Porphyromonas gingivalis. Biosci Biotechnol Biochem 1996;60:745-749.
10.
Wang YF, Shao SH, Xu P, et al: Catechin enriched green tea extract as a safe and effective agent for antimicrobial and anti-inflammatory treatment. Afr J Pharm Pharmacol 2011;5:1452-1461.
11.
Fassina G, Buffa A, Benelli R, et al: Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS 2002;16:939-941.
12.
Fani MM, Kohanteb J, Dayaghi M: Inhibitory activity of garlic (Allium sativum) extract on multidrug-resistant Streptococcus mutans. J Indian Soc Pedod Prev Dent 2007;25:164-168.
13.
Fani MM, Kohanteb J: Inhibitory activity of Aloe vera gel on some clinically isolated cariogenic and periodontopathic bacteria. J Oral Sci 2012;54:15-21.
14.
Kohanteb J, Sadeghi E: Penicillin-resistant Streptococcus pneumoniae in Iran. Med Princ Pract 2007;16:29-33.
15.
Ikigai H, Nakae T, Hara Y, et al: Bactericidal catechins damage the lipid bilayer. Biochim Biophys Acta 1999;1147:132-136.
16.
Sakanaka S, Okada Y: Inhibitory effects of green tea polyphenols on the production of virulence factor of the periodontal-disease-causing anaerobic bacterium Porphyromonas gingivalis. J Agric Food Chem 2004;52:1688-1692.
17.
Gradisar H, Pristovsek P, Plaper A, et al: Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site. J Med Chem 2007;50:264-271.
18.
Okamoto M, Leung KP, Anasi T, et al: Inhibitory effects of green tea catechins on protein tyrosine phosphatase in Prevotella intermedia. Oral Microbiol Immunol 2003;18:192-195.
19.
Hirasawa M, Takada K, Makimura M, et al: Improvement of periodontal status by green tea catechin using a local delivery system: a clinical pilot study. J Periodontal Res 2002;37:433-438.
20.
Hattori M, Kusumoto IT, Namba T, et al: Effect of tea polyphenols on glucan synthesis by glucosyltransferase from Streptococcus mutans. Chem Pharm Bull (Tokyo) 1990;38:717-720.
21.
Hamilton-Miller JMT: Anticariogenic properties of tea (Camellia sinensis). J Med Microbiol 2001;50:299-302.
22.
Beaudouin E, Kanny G, Morrisset M, et al: Immediate hypersensitivity to chlorhexidine: literature review. Allerg Immunol (Paris) 2004;36:123-126.
23.
Chang YC, Huang FM, Tai KW, et al: The effects of sodium hypochlorite and chlorhexidine on cultured human periodontal ligament cells. Oral Surg Oral Med Oral Path Oral Radiol Endod 2001;92:446-450.
24.
Cowan MM: Plants products as antimicrobial agents. Clin Microbiol Rev 1999;12:564-582.
25.
Takarada K, Kimizuka R, Takahashi N, et al: Comparison of the antibacterial efficacies of essential oils against oral pathogens. Oral Microbiol Immunol 2004;19:61-64.
26.
Sasaki H, Matsumoto M, Tanaka T, et al: Antibacterial activity of polyphenol components in Oolong tea extract against Streptococcu s mutans. Caries Res 2004;38:2-8.
27.
Xu X, Zhou D, Wu CD: The tea catechin epigallocatechin gallate suppresses cariogenic virulence factors of Streptococcus mutans. Antimicrob Agents Chemother 2011;55:1229-1236.
28.
Muroi H, Kubo I: Combination effects of antibacterial compounds in green tea flavor against Streptococcus mutans. J Agric Food Chem 1993;41:1102-1105.
29.
Gloro R, Hourmand-Ollivier I, Mosquet B: Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol 2005;17:1135-1137.
30.
Ahn WS, Yoo J, Huh SW, et al: Protective effects of green tea extract on human cervical lesions. Eur J Cancer Prev 2003;12:383-390.
Open Access License / Drug Dosage / Disclaimer
Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.